Hirsutism, Postpartum Telogen Effluvium, and Male Pattern Alopecia

The 2006 document reviews how hormonal changes during and after pregnancy affect hair growth, focusing on conditions such as hirsutism, postpartum telogen effluvium, and male pattern alopecia in women. It explains that hormonal fluctuations can lead to increased hair mass and changes in hair characteristics, with postpartum hair loss typically occurring 3 to 6 months after childbirth due to a large number of hairs entering the telogen phase. Hirsutism may indicate underlying conditions like tumors or polycystic ovaries, while postpartum telogen effluvium is generally self-limiting. Treatment options for postpartum alopecia include minoxidil, but 5 alpha reductase inhibitors are contraindicated for women of childbearing potential. The document also notes the potential benefits of new oral contraceptives and antiandrogen therapy for acne and female alopecia, underscoring the need for patient education and support during these periods of change.